Genomic Valley Biotech Ltd — Board Meeting, 15-10-2025: Board Meeting
15-10-2025 | 03:26 pm
15-10-2025 | 03:26 pm
Genomic Valley Biotech's Q2/H1 FY25 financial results show Net Profit plunged to INR 2.79 Lakh. Operating cash flow was negative INR 3.82 Lakh, with cash & equivalents at INR 0.71 Lakh. A sharp operational downturn noted.
No comments yet. Be the first to comment!
